MENU
XENE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Xenon Pharmaceuticals (XENE) Earnings Date & Reports
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
XENE is expected to report earnings to rise 5.41% to -116 cents per share on November 02
Q3'26
Est.
$-1.17
Q2'26
Beat
by $0.03
Q1'26
Beat
by $0.01
Q4'25
Missed
by $0.12
Q3'25
Est.
$-1.15
The last earnings report on August 06 showed earnings per share of -111 cents, beating the estimate of -113 cents. With 337.93K shares outstanding, the current market capitalization sits at 3.42B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a provider of drug discovery and development services
Industry Biotechnology
Industry
Biotechnology
Address
200-3650 Gilmore Way
Phone
+1 604 484-3300
Employees
370
Web
https://www.xenon-pharma.com